Williams, Lewis T.
United States
 |
No tags have been applied so far. Sign in to add some. |
|
|
|
Williams, Lewis T.
🏭 Profile
📑 Documents (0)
🏛 Litigation (28)
Over Time
🖋 Attorneys (635)
📈 Stock Market (75)
🔗 Related (6)
💡 Patent Assignments (57)
™️ Trademark Assignments (0)
💰 Payments (0)
|
Outside Counsel (635)
|
|
Chen |
Weichuan |
Caroline |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Chen |
Weiguo |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Palo Alto, CA |
|
|
|
Cheng |
Shing-Yi |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Cheslow |
Ernest (Inactive) |
|
WAGNER & AUBEL |
|
|
|
|
Chin |
Khin |
K. |
Bozicevic Field & Francis LLP |
Redwood City, CA |
|
|
|
Ching |
Edwin |
I. |
Kilpatrick Townsend & Stockton, LLP |
San Francisco, CA |
|
|
|
Cho |
Hojung |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
CHOI |
WENDY |
|
Rohm And Haas Company |
PHILADELPHIA, PA |
|
|
|
Christiansen |
Richard |
|
Sharp Kabushiki Kaisha |
San Diego, CA |
|
|
|
CHUNG |
DANIEL |
G |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
CHUNG |
LING-FONG |
|
Chiron Corporation |
|
|
|
|
Ciminello |
Dominic |
|
Harter Secrest & Emery LLP |
|
|
|
|
Citroen |
Phillip |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Clark |
Kevin |
Michael |
Kilpatrick Townsend & Stockton, LLP |
San Diego, CA |
|
|
|
COLLAZO |
MARIE |
|
Allied-Signal, Inc. |
MORRISTOW, NJ |
|
|
|
COLWELL |
ROBERT |
|
Kilpatrick Townsend & Stockton, LLP |
|
|
|
|
Connor |
Jeffrey |
|
Kilpatrick Townsend & Stockton, LLP |
DENVER, CO |
|
|
|
Converse |
Robert |
|
ANTHONY J. DELAURENTIS, PA |
|
|
|
|
Cook |
Elliot |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
RESTON, VA |
|
|
|
Cook |
Roger |
Lee |
Kilpatrick Townsend & Stockton, LLP |
San Francisco, CA |
|
|
|
Cooley |
Daniel |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Coyne |
Patrick |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Craig |
Joyce |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
CRALL |
KRISTIN |
|
Kilpatrick Townsend & Stockton, LLP |
ATLANTA, GA |
|
|
|
Craven |
Sarah |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Cretsinger |
Cathy |
E. |
Kilpatrick Townsend & Stockton, LLP |
|
|
|
|
Crisp |
Brandon |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Crockett |
Ryan |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Crookston |
Matthew |
B. |
|
|
|
|
|
Crowder |
Clifford |
D. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Curylo |
Robert |
J. |
Kilpatrick Townsend & Stockton, LLP |
Atlanta, GA |
|
|
|
D'Avignon-Aubut |
Christian |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Dai |
Angela |
|
Novo Nordisk A/S |
|
|
|
|
Dailey |
Robert |
|
Kilpatrick Townsend & Stockton, LLP |
Washington, DC |
|
|
|
Daley |
Kathleen |
|
Novo Nordisk A/S |
|
|
|
|
Daley |
William |
|
Sharp Kabushiki Kaisha |
Minneapolis, MN |
|
|
|
Danek |
Brenda |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Dave |
Urmil |
|
Kilpatrick Townsend & Stockton, LLP |
|
|
|
|
Davis |
John |
|
Wood Herron & Evans, LLP |
Downey, CA |
|
|
|
Davis |
Kimberlynn |
|
Union Bank Bldg |
Atlanta, GA |
|
|
|
Davis |
Walter |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
WASHINGTON, |
|
|
|
Davy |
Brian |
|
QUINE INTELLECTUAL PROPERTY LAW GROUP, PC |
|
|
|
|
DeCosta |
Frank |
|
Novo Nordisk A/S |
Washington, DC |
|
|
|
DeFranco |
Denise |
W. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Belmont, MA |
|
|
|
Dehlinger |
Peter |
J. |
LAW OFFICE OF PETER J. DEHLINGER |
|
|
|
|
Derrick |
Wesley |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Diner |
Bryan |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Ding |
Cathy |
C. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Dobson |
Allison |
W. |
|
Winston-salem, Nc, |
|
|
|
Dodson |
Richard |
P. |
Kilpatrick Townsend & Stockton, LLP |
ATLANTA, GA |
|
|
|
Doherty |
Elizabeth |
A. |
Mcneill Baur Pllc |
|
|
|
|
Dow |
Karen |
B. |
|
|
|
|
|
Doyle |
Kristin |
Johnson |
Kilpatrick Townsend & Stockton, LLP |
Atlanta, GA |
|
|
|
Dressler |
Max |
|
JOSEPH M. SORRENTINO |
Chicago, IL |
|
|
|
Dubal |
Uttam |
G. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Dunner |
Donald |
R. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Durkee |
Christopher |
M. |
Kilpatrick Townsend & Stockton, LLP |
Atlanta, GA |
|
|
|
Dyer |
William |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
ATLANTA, GA |
|
|
|
EDMONDSON |
JAMES |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Edwards |
Gary |
James |
Haynes & Boone, LLP |
Palo Alto, CA |
|
|
|
Edwards |
Nathaniel |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
CAMBRIDGE, MA |
|
|
|
Elluru |
Rama |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Elmer |
Michael |
C |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Eman |
Matthew |
Van |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
BOSTON, MA |
|
|
|
Emsley |
Rachel |
Lauren |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Engle |
Samuel (Inactive) |
|
Rosenblatt & Associates, PC |
|
|
|
|
Epstein |
Robert |
H. |
Finnan & Lytle, Llc |
ROCKVILLE, MD |
|
|
|
Eramian |
David |
|
Bozicevic Field & Francis LLP |
|
|
|
|
Esfahani |
Houtan |
Khalili |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Ethier |
Marquerite (Inactive) |
|
Patent Law Group |
|
|
|
|
Eurek |
Justin |
J. |
Kilpatrick Townsend & Stockton, LLP |
SAN FRANCISCO, CA |
|
|
|
Evans |
Marc |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Ewing |
James |
Lindsay |
Kilpatrick Townsend & Stockton, LLP |
Atlanta, GA |
|
|
|
Farabow |
Ford |
|
Scully, Scott, Murphy & Presser, PC |
|
|
|
|
Feld |
Nathan |
|
Kilpatrick Townsend & Stockton, LLP |
|
|
|
|
Feldstein |
Mark |
J |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Feng |
Li |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Ferguson |
Mary |
K. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Fernandez |
Lizette |
|
Kilpatrick Townsend & Stockton, LLP |
|
|
|
|
Ferrario |
Matias |
|
Kilpatrick Townsend & Stockton, LLP |
Winston-salem, Nc, |
|
|
|
Ferrill |
Elizabeth |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Field |
Bret |
|
bozpat.com Law Firm Placeholder |
EAST PALO ALTO, CA |
|
|
|
FISCHER |
LESLIE |
|
Novartis Pharmaceuticals Corporation |
|
|
|
|
Flanagan |
Lisa |
|
Kilpatrick Townsend & Stockton, LLP |
|
|
|
|
Flibbert |
Michael |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Foley |
Christopher |
Pratt |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Fordis. |
Jean |
Burke |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Forest |
Jeremy |
S. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Palo Alto, CA |
|
|
|
Forman |
David |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Foster |
Bryan |
Stuart |
Kilpatrick Townsend & Stockton, LLP |
Winston-salem, Nc, |
|
|
|
Foulds |
Glenn |
J. |
bozpat.com Law Firm Placeholder |
|
|
|
|
FRANCIS |
CAROL |
|
Bozicevic Field & Francis LLP |
Menlo Park, CA |
|
|
|
Franklin |
Thomas |
D. |
Kilpatrick Townsend & Stockton, LLP |
DENVER, CO |
|
|
|
Frazier |
David |
Penn |
Latham & Watkins LLP |
Washington, DC |
|
|
|
Freeman |
Jeffrey |
A. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Freeman. |
Kia |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
Fuchs |
Martin |
|
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Fues |
Eric |
J. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
|
|
|
|
Fuess |
William |
|
JOHN P. DORITY |
|
|
|
|
Gabriel |
Raymond |
M. |
Finnegan, Henderson, Farabow, Garrett & Dunn... |
Washington, DC |
|
|
|
|
2/18/2026 |
Protagonist Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
2/17/2026 |
|
144 |
Notice of proposed sale of securities pursuant to Rule 144 under... |
|
|
|
1/6/2026 |
Protagonist Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/6/2025 |
Protagonist Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/4/2024 |
Protagonist Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/18/2023 |
Protagonist Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
5/27/2022 |
Protagonist Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
2/9/2022 |
Arcellx, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
2/3/2022 |
Arcellx, Inc. |
3 |
Initial statement of beneficial ownership of securities |
|
|
|
5/28/2021 |
|
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
5/13/2021 |
|
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
5/29/2020 |
Protagonist Inc |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
5/7/2020 |
Aquinox Pharmaceuticals (usa) Inc |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
10/15/2019 |
Aquinox Pharmaceuticals (usa) Inc |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
9/4/2019 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
8/12/2019 |
Aquinox Pharmaceuticals (usa) Inc |
3 |
Initial statement of beneficial ownership of securities |
|
|
|
6/12/2019 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
6/11/2019 |
Protagonist Inc |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
2/28/2019 |
Five Prime Therapeutics, Inc. |
4/A |
|
|
|
|
2/27/2019 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
2/7/2019 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
11/13/2018 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
9/5/2018 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
6/12/2018 |
Protagonist Inc |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
2/28/2018 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
2/13/2018 |
Five Prime Therapeutics, Inc. |
4/A |
|
|
|
|
2/13/2018 |
Five Prime Therapeutics, Inc. |
4/A |
|
|
|
|
2/7/2018 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
9/6/2017 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
6/15/2017 |
Protagonist Inc |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
6/8/2017 |
Protagonist Inc |
3 |
Initial statement of beneficial ownership of securities |
|
|
|
3/3/2017 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
2/9/2017 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
1/5/2017 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
12/23/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
9/15/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
9/1/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
8/29/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
5/13/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
4/22/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
4/18/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
4/15/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
4/7/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
3/31/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
3/3/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
2/8/2016 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
12/28/2015 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
11/18/2015 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
10/26/2015 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
10/19/2015 |
Five Prime Therapeutics, Inc. |
4 |
Statement of changes in beneficial ownership of securities |
|
|
|
|
8/24/2023 |
Walking Fish Therapeutics |
Assignee |
Application Publication |
18314778 20240002793 |
Modified B Cells And Methods Of Use Thereof Modified B Cells And Methods Of Use Thereof |
|
|
|
7/25/2023 |
Walking Fish Therapeutics |
Assignee |
Application Publication Patent |
18316198 20240034995 12037604 |
Modified B Cells And Methods Of Use Thereof Modified B Cells And Methods Of Use Thereof Modified B Cells And Methods Of Use Thereof |
|
|
|
4/26/2022 |
Walking Fish Therapeutics |
Assignee |
Application Publication |
17465759 20220073876 |
Modified B Cells And Methods Of Use Thereof Modified B Cells And Methods Of Use Thereof |
|
|
|
12/15/2015 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
14773329 20160017024 |
Fam150a, Fam150b, And Fam150 Antagonists And Uses Thereof Fam150a, Fam150b, And Fam150 Antagonists And Uses Thereof |
|
|
|
1/2/2014 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication Patent |
14048841 20140140995 9192683 |
Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Methods Of Treating Disease With Fgfr1 Fusion Proteins |
|
|
|
12/11/2013 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
14019684 20140086840 |
Therapeutic Antibody Target Validation and Screening In Vivo Therapeutic Antibody Target Validation and Screening In Vivo |
|
|
|
11/6/2013 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
14048834 20140170145 |
Compositions And Methods Of Use For Mgd-csf In Disease Treatment Compositions And Methods Of Use For Mgd-csf In Disease Treatment |
|
|
|
8/12/2013 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication Patent |
13905042 20130324701 9173957 |
Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Fgfr2 Fusion Proteins Comprising C-terminal Deletion Mutants Of Fgfr2-ii... |
|
|
|
8/12/2013 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication Patent |
13227398 20130065276 8580936 |
Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins POLYNUCLEOTIDES ENCODING FGFR1-lllc ECD FUSION PROTEINS |
|
|
|
11/16/2012 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication Patent |
13446254 20120258071 8575312 |
Compositions and Methods of Use for MGD-CSF in Disease Treatment Compositions and Methods of Use for MGD-CSF in Disease Treatment Compositions And Methods Of Use For Mgd-csf In Disease Treatment |
|
|
|
2/28/2012 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
13378318 20120183477 |
Therapeutic Antibody Target Validation and Screening In Vivo Therapeutic Antibody Target Validation and Screening In Vivo |
|
|
|
8/30/2011 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication Patent |
12992582 20110288024 8324165 |
Compositions For Treating Arthritis Comprising Hg1023575 Polypeptide Compositions For Treating Arthritis Comprising Hg1023575 Polypeptide Compositions For Treating Arthritis Comprising Hg1023575 Polypeptide |
|
|
|
1/8/2008 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Application Publication Publication Patent Patent |
11795915 11795915 20090018061 20090018061 8168588 8168588 |
Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... Compositions Comprising Fgf-9 And Betacellulin And Methods For Treating ... |
|
|
|
1/8/2008 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
11442244 20070054851 |
Methods of and compositions for stimulation of glucose uptake into muscl... Methods of and compositions for stimulation of glucose uptake into muscl... |
|
|
|
1/8/2008 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Application Publication Publication |
11632319 11632319 20070264277 20070264277 |
Compositions and Methods of Use for Mgd-Csf in Disease Treatment Compositions and Methods of Use for Mgd-Csf in Disease Treatment Compositions and Methods of Use for Mgd-Csf in Disease Treatment Compositions and Methods of Use for Mgd-Csf in Disease Treatment |
|
|
|
1/8/2008 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Application Publication Patent Patent |
11587651 11587651 20100062009 7776564 7776564 |
Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ... Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ... Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ... Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ... Stromal Cell-derived Factor-1 Polypeptides, Polynucleotides, Modulators ... |
|
|
|
5/30/2007 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication Patent |
11791889 20080171689 7678890 |
Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins |
|
|
|
3/2/2007 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication Patent |
11791889 20080171689 7678890 |
Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins Compositions And Methods Of Treating Disease With Fgfr Fusion Proteins |
|
|
|
3/2/2007 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
10583146 20070248605 |
Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeut... Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeut... |
|
|
|
2/2/2007 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
10591451 20070258949 |
Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and M... Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and M... |
|
|
|
1/18/2007 |
Chiron Corporation |
Assignee |
Application Publication |
11654824 20070128710 |
Novel protein associated with cell stress response Novel protein associated with cell stress response |
|
|
|
9/28/2006 |
Novartis Vaccines And Diagnostics, Inc. |
Assignee |
Application Publication Patent |
10644548 20040137569 7279554 |
Notch Receptor Ligands And Uses Thereof Notch Receptor Ligands And Uses Thereof Notch Receptor Ligands And Uses Thereof |
|
|
|
8/15/2006 |
The Regents Of The University Of Califor... |
Assignee |
Application Patent |
08423646 6280964 |
Binding Sites For Phosphotyrosine Binding Domains Binding Sites For Phosphotyrosine Binding Domains |
|
|
|
12/19/2005 |
Chiron Corporation |
Assignee |
Application Publication |
10498033 20060275747 |
Endogenous retrovirus up-regulated in prostate cancer Endogenous retrovirus up-regulated in prostate cancer |
|
|
|
12/14/2005 |
Chiron Ocrporation |
Assignee |
Application Publication |
10497786 20070037147 |
Endogenous retrovirus polypeptides linked to oncogenic transformation Endogenous retrovirus polypeptides linked to oncogenic transformation |
|
|
|
11/3/2005 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
11003840 20060035373 |
Stem cell libraries Stem cell libraries |
|
|
|
6/7/2005 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
10516605 20050244970 |
Stem cell libraries Stem cell libraries |
|
|
|
5/31/2005 |
The Regents Of The University Of Califor... |
Assignee |
Application Publication Patent |
10464939 20040005688 6958238 |
Isolated Dishevelled Associated Kinases, Polynucleotides Encoding The Ki... Isolated Dishevelled Associated Kinases, Polynucleotides Encoding The Ki... Isolated Dishevelled Associated Kinases, Polynucleotides Encoding The Ki... |
|
|
|
5/31/2005 |
Five Prime Therapeutics, Inc. |
Assignee |
Application Publication |
10948571 20060084799 |
Human cDNA clones comprising polynucleotides encoding polypeptides and m... Human cDNA clones comprising polynucleotides encoding polypeptides and m... |
|
|
|
3/18/2005 |
Chiron Corporation |
Assignee |
Application Publication Patent |
10779543 20050227917 8101349 |
Gene Products Differentially Expressed In Cancerous Cells And Their Meth... Gene Products Differentially Expressed In Cancerous Cells And Their Meth... Gene Products Differentially Expressed In Cancerous Cells And Their Meth... |
|
|
|
7/30/2004 |
Chiron Corporation |
Assignee |
Application Publication Patent |
10016604 20100136522 7776523 |
Endogenous Retroviruses Up-regulated In Prostate Cancer Endogenous Retroviruses Up-regulated In Prostate Cancer Endogenous Retroviruses Up-regulated In Prostate Cancer |
|
|
|
7/7/2004 |
Chiron Corporation |
Assignee |
Application Publication |
10076555 20030065156 |
Novel human genes and gene expression products I Novel human genes and gene expression products I |
|
|
|
7/1/2004 |
Chiron Corporation |
Assignee |
Application Publication |
10609021 20040086913 |
Human genes and gene expression products XVI Human genes and gene expression products XVI |
|
|
|
6/29/2004 |
Chiron Corporation |
Assignee |
Application Publication |
09854124 20020076735 |
Diagnostic and therapeutic methods using molecules differentially expres... Diagnostic and therapeutic methods using molecules differentially expres... |
|
|
|
3/29/2004 |
Chiron Corporation |
Assignee |
Application Publication |
10601610 20040091898 |
PI 3-kinase fusion mutants and uses thereof PI 3-kinase fusion mutants and uses thereof |
|
|
|
5/1/2002 |
Chiron Corporation |
Assignee |
Application Publication |
09803719 20030044783 |
Human genes and gene expression products Human genes and gene expression products |
|
|
|
4/16/2001 |
Chiron Corporation |
Assignee |
Application Patent |
09641612 6703221 |
Notch Receptor Ligands And Uses Thereof Notch Receptor Ligands And Uses Thereof |
|
|
|
4/13/2001 |
Chiron Corporation |
Assignee |
Application Patent |
09641612 6703221 |
Notch Receptor Ligands And Uses Thereof Notch Receptor Ligands And Uses Thereof |
|
|
|
8/14/2000 |
Chiron Corporation |
Assignee |
Application Patent |
09544776 7186530 |
Novel Protein Associated With Cell Stress Response Novel Protein Associated With Cell Stress Response |
|
|
|
5/11/2000 |
Chiron Corporation |
Assignee |
Application Patent |
09472112 6512102 |
Compositions And Methods Of Diagnosis And Treatment Using Casein Kinase ... Compositions And Methods Of Diagnosis And Treatment Using Casein Kinase ... |
|
|
|
1/10/2000 |
Chiron Corporation |
Assignee |
Application Patent |
09297648 6964868 |
Human Genes And Gene Expression Products Ii Human Genes And Gene Expression Products Ii |
|
|
|
10/18/1999 |
Chiron Corporation |
Assignee |
Application Patent |
09313292 7122373 |
Novel Human Genes And Gene Expression Products V Novel Human Genes And Gene Expression Products V |
|
|
|
2/18/1999 |
Chiron Corporation |
Assignee |
Application Patent |
09206344 6432668 |
Polynucleotides Encoding Human Cyclin-dependent Kinase (hpftaire) Polynucleotides Encoding Human Cyclin-dependent Kinase (hpftaire) |
|
|
|
2/1/1999 |
Chiron Corporation |
Assignee |
Application Patent |
09195868 6090621 |
Signaling Inositol Polyphosphate 5-phosphatases (sips) Signaling Inositol Polyphosphate 5-phosphatases (sips) |
|
|
|
4/28/1998 |
Regents Of The University Of California |
Assignee |
Application Patent |
08982493 6110695 |
Modulating The Interaction Of The Chemokine, B Lymphocyte Chemoattractan... Modulating The Interaction Of The Chemokine, B Lymphocyte Chemoattractan... |
|
|
|
10/17/1997 |
Chiron Corporation |
Assignee |
Application Patent |
08861745 6165733 |
Gamma Ii Adaptin Gamma Ii Adaptin |
|
|
|
7/14/1997 |
Chiron Corporation |
Assignee |
Application Patent |
08832571 6613956 |
Pi-3-kinase Fusion Mutants And Uses Thereof Pi-3-kinase Fusion Mutants And Uses Thereof |
|
|
|
2/28/1997 |
Regents Of The University Of California |
Assignee |
Application Patent |
08751512 6001962 |
Modified Fas Ligands Modified Fas Ligands |
|
|
|
6/17/1996 |
Regents Of The University Of California |
Assignee |
Application Patent |
08609049 5948664 |
Novel Pi 3-kinase Polypeptides Novel Pi 3-kinase Polypeptides |
|
|
|
3/25/1996 |
Regents Of The University Of California |
Assignee |
Application Patent |
08560005 6001354 |
Novel Grb2 Associating Polypeptides And Nucleic Acids Encoding Therefor Novel Grb2 Associating Polypeptides And Nucleic Acids Encoding Therefor |
|
|
Incoming Payments
Outgoing Payments
|
|